Home Transmembrane Transporters CFTR

CFTR Inhibitors

Cat.No. Product Name Information Product Use Citations Product Validations
S8535 Galicaftor (ABBV-2222) Galicaftor (ABBV-2222, GLPG2222) is a potent corrector of CFTR for the treatment of Cystic Fibrosis (CF).
Front Pharmacol, 2024, 15:1494327
Biology, 2022, (182)-
J Vis Exp, 2022, (182)
S8094 GlyH-101 GlyH-101 is a selective and reversible CFTR inhibitor with a Ki of 4.3 μM.
mBio, 2023, 14(5):e0151623
Cell Mol Immunol, 2020, 10.1038/s41423-020-0499-3
S7329 IOWH032 IOWH032 is a synthetic CFTR inhibitor with IC50 of 1.01 μM in CHO-CFTR cell based assays. Phase 2.
Sci Rep, 2023, 13(1):3934
S0198 PPQ-102 PPQ-102 (CFTR Inhibitor IV) is a potent inhibitor of CFTR. This compound can completely inhibit CFTR chloride current with an IC50 of ~90 nM.
Cells, 2023, 12(5)776
S6911 Nesolicaftor (PTI-428) Nesolicaftor (PTI-428) is a specific cystic fibrosis transmembrane conductance regulator (CFTR) amplifier that increases CFTR expression.
S6599 KM11060 KM11060 is a small molecule that corrects the processing of cystic fibrosis transmembrane conductance regulator (CFTR) proteins bearing the F508 deletion (F508del) mutation.
S9972 Icenticaftor (QBW251)

Icenticaftor (QBW251, NVP-QBW251) is an oral potentiator of the cystic fibrosis transmembrane conductance regulator (CFTR) channel with EC50 of 79 nM and 497 nM for F508del CFTR and G551D CFTR in Fisher Rat Thyroid (FRT) cells.
S3272 Steviol (Hydroxydehydrostevic acid) Steviol (Hydroxydehydrostevic acid, Hydroxy Dehydrostevic Acid, NSC 226902), a major metabolite of the sweetening compound stevioside, inhibits CFTR activity, reduces AQP2 expression and promotes AQP2 degradation.